RE: News soon7 Jan 2016 16:53
Deadline for the implementation of the policy is 4th May 2016.
From the last RNS, dated 4th November 2015....."In the event that the Company is unable to implement its investing policy within the next six months (i.e. by 4 May 2016), admission of the Company's shares will be cancelled in accordance with Rule 41 of the AIM Rules. "
So either the proposed acquisition of SalvaRx Limited ("SalvaRx") has to have taken place by this point..... or,
other investments will need to be made to enable the policy to be said to have been implemented.
In any case, the 4th May 2016 is the drop dead date but I am hoping for news well before then.
From the same RNS..."Due to its size in relation to the Company, the proposed acquisition of SalvaRx would constitute a "reverse takeover" under the AIM Rules. Therefore the Company's shares will remain suspended until such time as either an admission document setting out details of the proposed acquisition is published or, in the event that the transaction does not proceed, the Company has taken other steps to implement its Investing Policy".